Aurinia Pharmaceuticals Inc.
AUPH
$12.27
$0.191.57%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Net Income | 60.64M | 39.85M | 5.75M | -22.55M | -50.35M |
| Total Depreciation and Amortization | 19.48M | 19.45M | 19.45M | 19.53M | 19.90M |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 21.39M | 14.39M | 14.39M | 29.85M | 28.83M |
| Change in Net Operating Assets | -8.82M | -9.41M | 4.80M | 1.76M | -97.00K |
| Cash from Operations | 92.68M | 64.29M | 44.39M | 28.59M | -1.72M |
| Capital Expenditure | -396.00K | -426.00K | -421.00K | -439.00K | -334.00K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 46.81M | 21.49M | 39.68M | -5.78M | -15.01M |
| Cash from Investing | 46.41M | 21.06M | 39.26M | -6.22M | -15.35M |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -12.19M | -11.98M | -11.99M | -15.50M | -16.03M |
| Issuance of Common Stock | 19.15M | 18.76M | 15.00M | 10.32M | 11.23M |
| Repurchase of Common Stock | -126.46M | -90.16M | -52.10M | -26.44M | -26.44M |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -119.50M | -83.38M | -49.09M | -31.62M | -31.23M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 19.60M | 1.97M | 34.56M | -9.26M | -48.30M |